Does the levels of vitamin D correlate with the levels of vitamin B12 and ferritin in fibromyalgia?
Does vitamin D correlate with vitamin B12 and ferritin?
Keywords:
fibromyalgia, neuroinflammation, vitamin DAbstract
Background/Aim: Considering the effects of inflammation on fibromyalgia and the small intestine, we hypothesize that vitamin D deficiency may contribute to inflammation and affect vitamin B12 and ferritin levels in patients with fibromyalgia. The objectives were: 1) to compare the levels of vitamin D, vitamin B12, and ferritin in patients with fibromyalgia and patients who have local painful conditions, and 2) to evaluate the correlation of vitamin D levels with vitamin B12 and ferritin levels.
Methods: The records of 299 patients with fibromyalgia (274 female, 25 male) and 128 patients with local painful conditions (114 female, 14 male) between April 2019 and 2020 were examined, including measurements of 25-hydroxy vitamin D, vitamin B12, ferritin, erythrocyte sedimentation rate, and C-reactive protein.
Results: The levels of 25-hydroxy vitamin D were low in both groups, with levels below 30 ng/ml in 90.3% of all patients. However, there was no significant difference in vitamin B12 and ferritin levels between the two groups, and the levels of these markers were within normal limits in both groups. Correlation analysis showed that vitamin D levels were significantly correlated with vitamin B12 (P<0.001, r=0.211) and ferritin (P=0.005, r=0.337) levels in patients with fibromyalgia but not in the other group.
Conclusion: Consistent with our hypothesis, an association was found between vitamin D levels and vitamin B12 and ferritin levels in fibromyalgia. However, this correlation was not found in patients with local painful conditions.
Downloads
References
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33(2):160-72. doi: 10.1002/art.1780330203 DOI: https://doi.org/10.1002/art.1780330203
Arranz L, Canela M, Rafecas M. Fibromyalgia and nutrition, what do we know? Rheumatol Int. 2010;30(11):1417–27. doi: 10.1007/s00296-010-1443-0 DOI: https://doi.org/10.1007/s00296-010-1443-0
Ortancil O, Sanli A, Eryuksel R, Basaran A, Ankarali H. Association between serum ferritin level and fibromyalgia syndrome. Eur. J. Clin. Nutr. 2010;64(3):308-12. doi: 10.1038/ejcn.2009.149 DOI: https://doi.org/10.1038/ejcn.2009.149
Mader R, Koton Y, Buskila D, Herer P, Elias M. Serum iron and iron stores in non-anemic patients with fibromyalgia. Clin. Rheumatol. 2012;31(4):595-9. doi: 10.1007/s10067-011-1888-x DOI: https://doi.org/10.1007/s10067-011-1888-x
Bottiglieri T. Homocysteine and folate metabolism in depression progress. Neuro-Psychopharmacol. Biol. Psychiatry. 2005;29(7):1103-12. doi: 10.1016/j.pnpbp.2005.06.021 DOI: https://doi.org/10.1016/j.pnpbp.2005.06.021
Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013:424651. doi: 10.1155/2013/424651 DOI: https://doi.org/10.1155/2013/424651
De Carvalho JF, Silva DNF. Serum levels of vitamin B12 (cobalamin) in fibromyalgia. Rheumatology international. 2016;36(5):741-2. doi: 10.1007/s00296-016-3454-y DOI: https://doi.org/10.1007/s00296-016-3454-y
Akar N, Çaglar NS, Aytekin E, Akar A, Aksu Ö, Öz N. Low levels of serum vitamin D3 are associated with fibromyalgia syndrome in pre-menopausal women: A pilot study. Turk J Phys Med Rehabil. 2020;66(1):67-72. doi: 10.3906/sag-1508-30 DOI: https://doi.org/10.5606/tftrd.2020.2928
Ozcan DS, Oken O, Aras M, Koseoglu BF. Vitamin D levels in women with fibromyalgia and relationship between pain, depression, and sleep. Turk J Phys Med Rehabil. 2014;60(4):329-35. doi: 10.5152/tftrd.2014.45143 DOI: https://doi.org/10.5152/tftrd.2014.45143
Özgen M, Aydoğan AM, Uygur A, Armağan O, Berkan F, Mutlu F. Fibromiyalji Sendromunda D Vitamin Düzeylerinin Değerlendirilmesi. OJM. 2018;41(2):161-5. doi: 10.20515/otd.459018 DOI: https://doi.org/10.20515/otd.459018
Backryd E, Tanum L, Lind AL, Larsson A, Gordh T. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017;10:515–25. doi: 10.2147/JPR.S128508 DOI: https://doi.org/10.2147/JPR.S128508
Rodriguez-Pinto I, Agmon-Levin N, Howard A, Shoenfeld Y. Fibromyalgia and cytokines. Immunol Lett. 2014;161(2):200–3. doi: 10.1016/j.imlet.2014.01.009 DOI: https://doi.org/10.1016/j.imlet.2014.01.009
Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37(11):1593–601. DOI: https://doi.org/10.1002/art.1780371106
Vasquez, A. Neuroinflammation in fibromyalgia and CRPS is multifactorial. Nat Rev Rheumatol. 2016;12:242. doi: 10.1038/nrrheum.2016.25 DOI: https://doi.org/10.1038/nrrheum.2016.25
Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008;47:1223–7. doi: 10.1093/rheumatology/ken140 DOI: https://doi.org/10.1093/rheumatology/ken140
Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann. Rheum. Dis. 2004;63(4):450-2. doi: 10.1136/ard.2003.011502 DOI: https://doi.org/10.1136/ard.2003.011502
Peuhkuri K, Vapaatalo H, Korpela R. Even low-grade inflammation impacts on small intestinal function. World journal of gastroenterology. 2010;16(9):1057-62. doi: 10.3748/wjg.v16.i9.1057 DOI: https://doi.org/10.3748/wjg.v16.i9.1057
Mourad FH, Barada KA, Bou Rached NA, Khoury CI, Saadé NE, Nassar CF. Inhibitory effect of experimental colitis on fluid absorption in rat jejunum: role of the enteric nervous system, VIP, and nitric oxide. Am J Physiol Gastrointest Liver Physiol. 2006;290:262-8. doi: 10.1152/ajpgi.00271.2005 DOI: https://doi.org/10.1152/ajpgi.00271.2005
Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe‐Court D, Boucher BJ. Circulating MMP9, vitamin D and variation in the TIMP‐1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Qjm. 2002;95(12):787-96. doi: 10.1093/qjmed/95.12.787 DOI: https://doi.org/10.1093/qjmed/95.12.787
RafteryT, Martineau AR, Greiller CL, Ghosh S, McNamara D, Bennett K, et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. doi: 10.1177/2050640615572176 DOI: https://doi.org/10.1177/2050640615572176
Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, et al. Effects of high doses of vitamin D 3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. European journal of nutrition. 2016;55(4):1479-89. doi: 10.1007/s00394-015-0966-2 DOI: https://doi.org/10.1007/s00394-015-0966-2
Smith EM, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med. 1994;51:394-7. doi: 10.3906/sag-1710-81 DOI: https://doi.org/10.3906/sag-1710-81
Block SR. Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. In Mayo Clinic Proceedings. 2004;79(12):1585-6. doi: 10.4065/79.12.1585 DOI: https://doi.org/10.4065/79.12.1585
Atalay SG, Atalay R, Alkan BM, Fidan F, Bozkurt S, Aksekili H. Vitamin D deficiency in adults with musculoskeletal pain. Turk J Osteoporos. 2015;21(3):101-4. DOI: https://doi.org/10.4274/tod.19981
Ösken S, İçağasıoğlu A, Arslan P, Eğilmez Z, Murat S. D Vitamininin Kognitif Fonksiyonlarla İlişkisi: Genç Erişkin Kadınlarda Kesitsel Bir Çalışma. Turk J Osteoporos. 2016;22:137-40. DOI: https://doi.org/10.4274/tod.09326
Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-45. doi: 10.1146/annurev.nutr.23.011702.073114 DOI: https://doi.org/10.1146/annurev.nutr.23.011702.073114
Stumpf WE, Hayakawa N, Koike N, Hirate J, Okazaki, A. Nuclear receptors for 1, 25-dihydroxy-22-oxavitamin D 3 (OCT) and 1, 25-dihydroxyvitamin D 3 in gastric gland neck mucous cells and gastrin enteroendocrine cells. Histochem. Cell Biol. 1995;103(4):245-50. DOI: https://doi.org/10.1007/BF01457407
Antico A, Tozzoli R, Giavarina D, Tonutti E, Bizzaro N. Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case–control study and review of the literature on the interaction of vitamin D with the immune system. Clin Rev Allergy Immunol. 2012;42(3):355-64. doi: 10.1007/s12016-011-8255-1 DOI: https://doi.org/10.1007/s12016-011-8255-1
Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 1999;26(7):1564–9.
Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain. 2007;8(9):737–45. doi: 10.1016/j.jpain.2007.05.002 DOI: https://doi.org/10.1016/j.jpain.2007.05.002
Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol. 2012;242(1–2):33–8. doi: 10.1016/j.jneuroim.2011.10.013 DOI: https://doi.org/10.1016/j.jneuroim.2011.10.013
Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain. 2014;155(2):261-8. doi: 10.1016/j.pain.2013.10.002 DOI: https://doi.org/10.1016/j.pain.2013.10.002
Hur J, Lee P, Kim MJ, Cho YW. Regulatory effect of 25-hydroxyvitamin D3 on nitric oxide production in activated microglia. Korean J. Physiol. Pharmacol. 2014;18:397–402. doi: 10.4196/kjpp.2014.18.5.397 DOI: https://doi.org/10.4196/kjpp.2014.18.5.397
Luthold RV, Fernandes GR, Franco-de-Moraes AC, Folchetti LG, Ferreira SR. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017;69:76-86. doi: 10.1016/j.metabol.2017.01.007 DOI: https://doi.org/10.1016/j.metabol.2017.01.007
Littlejohn, G. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat. Rev. Rheumatol. 2015;11:639–48. doi: 10.1038/nrrheum.2015.100 DOI: https://doi.org/10.1038/nrrheum.2015.100
Curic N, Ilincic B, Milic N, Cabarkapa V, Nikolic S, Medic-Stojanoska M. The relationship between the vitamin serum 25 (OH) D and the B12 concentrations in obese women. Minerva medica. 2018;109(2):79-87. doi: 10.23736/s0026-4806.17.05447-7 DOI: https://doi.org/10.23736/S0026-4806.17.05447-7
Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun. 2014;42:10-21. doi: 10.1016/j.bbi.2014.04.001 DOI: https://doi.org/10.1016/j.bbi.2014.04.001
Aguilar-Valles A, Inoue W, Rummel C, Luheshi GN. Obesity, adipokines and neuroinflammation. Neuropharmacology. 2015;96:124-34. doi: 10.1016/j.neuropharm.2014.12.023. DOI: https://doi.org/10.1016/j.neuropharm.2014.12.023
Downloads
- 561 273
Published
Issue
Section
How to Cite
License
Copyright (c) 2023 Fulya Bakılan , Burcu Ortanca, Ayşe Ekim, Fezan Şahin Mutlu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.